Author Steven H. Dayan, MD reads his article “The Second of Two One-Year, Multicenter, Open-Label, Repeat-Dose, Phase II Safety Studies of PrabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients” published in the December 2021 issue of Aesthetic Surgery Journal.